Cargando…

Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study

BACKGROUND: In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-using individuals (OUI) needs to be improved. AIMS: Little has been published on...

Descripción completa

Detalles Bibliográficos
Autores principales: Liebrenz, Michael, Gamma, Alex, Buadze, Anna, Schleifer, Roman, Baggio, Stéphanie, Schwartz, Bruce, Schneeberger, Andres, Uchtenhagen, Ambros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552491/
https://www.ncbi.nlm.nih.gov/pubmed/33046103
http://dx.doi.org/10.1186/s12954-020-00412-0
_version_ 1783593411298721792
author Liebrenz, Michael
Gamma, Alex
Buadze, Anna
Schleifer, Roman
Baggio, Stéphanie
Schwartz, Bruce
Schneeberger, Andres
Uchtenhagen, Ambros
author_facet Liebrenz, Michael
Gamma, Alex
Buadze, Anna
Schleifer, Roman
Baggio, Stéphanie
Schwartz, Bruce
Schneeberger, Andres
Uchtenhagen, Ambros
author_sort Liebrenz, Michael
collection PubMed
description BACKGROUND: In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-using individuals (OUI) needs to be improved. AIMS: Little has been published on the effectiveness or outcomes of heroin-assisted treatment (HAT), a treatment option for severely dependent OUI delivered in a prison setting. The aim of this study was therefore to evaluate such treatment since its implementation. The primary objective was to investigate whether heroin-assisted treatment was associated with severe detrimental health outcomes. The secondary objective was to compare the heroin-assisted treatment group with the general prison population in terms of occupational functioning. DESIGN: Retrospective cohort study SETTING: An open prison with 120 places SUBJECTS: Data on 1885 male prisoners with a total of 2239 imprisonment periods between 2000 and 2015 was available. Ninety-seven inmates in heroin-assisted treatment were compared with 1788 inmates from the general prison population (reference group). MEASUREMENTS: Mortality, medical complications (including overdoses), and work performance (days worked, sick days, and monthly wages earned). FINDINGS: Inmates receiving HAT were on average 1 year younger (33.8 vs. 34.9 years), had longer prison stays (7.3 vs. 3.0 months), were more often of Swiss nationality (68.0% vs. 28.9%), and had committed more drug- and property-related offenses (49.5% vs. 23.2% and 63.9% vs. 38.3%, respectively) compared to the reference group. No serious heroin-related medical complication occurred during the 15-year window of observation among inmates with heroin-assisted treatment. Their work performance was comparable to that of the reference group. CONCLUSIONS: This study shows that heroin-assisted treatment can be a valuable treatment option for severely dependent OUI during imprisonment, can be delivered safely by prison health staff over extended periods of time, and allows OUI in treatment to achieve work performance rates comparable to that of the general prison population.
format Online
Article
Text
id pubmed-7552491
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75524912020-10-13 Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study Liebrenz, Michael Gamma, Alex Buadze, Anna Schleifer, Roman Baggio, Stéphanie Schwartz, Bruce Schneeberger, Andres Uchtenhagen, Ambros Harm Reduct J Research BACKGROUND: In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-using individuals (OUI) needs to be improved. AIMS: Little has been published on the effectiveness or outcomes of heroin-assisted treatment (HAT), a treatment option for severely dependent OUI delivered in a prison setting. The aim of this study was therefore to evaluate such treatment since its implementation. The primary objective was to investigate whether heroin-assisted treatment was associated with severe detrimental health outcomes. The secondary objective was to compare the heroin-assisted treatment group with the general prison population in terms of occupational functioning. DESIGN: Retrospective cohort study SETTING: An open prison with 120 places SUBJECTS: Data on 1885 male prisoners with a total of 2239 imprisonment periods between 2000 and 2015 was available. Ninety-seven inmates in heroin-assisted treatment were compared with 1788 inmates from the general prison population (reference group). MEASUREMENTS: Mortality, medical complications (including overdoses), and work performance (days worked, sick days, and monthly wages earned). FINDINGS: Inmates receiving HAT were on average 1 year younger (33.8 vs. 34.9 years), had longer prison stays (7.3 vs. 3.0 months), were more often of Swiss nationality (68.0% vs. 28.9%), and had committed more drug- and property-related offenses (49.5% vs. 23.2% and 63.9% vs. 38.3%, respectively) compared to the reference group. No serious heroin-related medical complication occurred during the 15-year window of observation among inmates with heroin-assisted treatment. Their work performance was comparable to that of the reference group. CONCLUSIONS: This study shows that heroin-assisted treatment can be a valuable treatment option for severely dependent OUI during imprisonment, can be delivered safely by prison health staff over extended periods of time, and allows OUI in treatment to achieve work performance rates comparable to that of the general prison population. BioMed Central 2020-10-13 /pmc/articles/PMC7552491/ /pubmed/33046103 http://dx.doi.org/10.1186/s12954-020-00412-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liebrenz, Michael
Gamma, Alex
Buadze, Anna
Schleifer, Roman
Baggio, Stéphanie
Schwartz, Bruce
Schneeberger, Andres
Uchtenhagen, Ambros
Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
title Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
title_full Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
title_fullStr Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
title_full_unstemmed Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
title_short Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
title_sort fifteen years of heroin-assisted treatment in a swiss prison—a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552491/
https://www.ncbi.nlm.nih.gov/pubmed/33046103
http://dx.doi.org/10.1186/s12954-020-00412-0
work_keys_str_mv AT liebrenzmichael fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT gammaalex fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT buadzeanna fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT schleiferroman fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT baggiostephanie fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT schwartzbruce fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT schneebergerandres fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy
AT uchtenhagenambros fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy